Skip Navigation


Cardiovascular Research Advance Access first published online on August 6, 2009
This version [Corrected Proof] published online on September 2, 2009

Cardiovascular Research, doi:10.1093/cvr/cvp273
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
cvp273v2    most recent
cvp273v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Blayney, L. M.
Right arrow Articles by Lai, F. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blayney, L. M.
Right arrow Articles by Lai, F. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.

A mechanism of ryanodine receptor modulation by FKBP12/12.6, protein kinase A, and K201

Lynda M. Blayney*, Jonathan-Lee Jones, Julia Griffiths and F. Anthony Lai

Department of Medicine - Cardiology, Wales Heart Research Institute, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK

* Corresponding author. Tel: +44 29 2074 4256, Fax: +44 29 2074 3500, Email: blayney{at}cf.ac.uk

Aims: Our objective was to explore the functional interdependence of protein kinase A (PKA) phosphorylation with binding of modulatory FK506 binding proteins (FKBP12/12.6) to the ryanodine receptor (RyR). RyR type 1 or type 2 was prepared from rabbit skeletal muscle or pig cardiac muscle, respectively. In heart failure, RyR2 dysfunction is implicated in fatal arrhythmia and RyR1 dysfunction is associated with muscle fatigue. A controversial underlying mechanism of RyR1/2 dysfunction is proposed to be hyperphosphorylation of RyR1/2 by PKA, causing loss of FKBP12/12.6 binding that is reversible by the experimental inhibitory drug K201 (JTV519). Phosphorylation is also a trigger for fatal arrhythmia in catecholaminergic polymorphic ventricular tachycardia associated with point mutations in RyR2.

Methods and results: Equilibrium binding kinetics of RyR1/2 to FKBP12/12.6 were measured using surface plasmon resonance (Biacore). Free Ca2+ concentration was used to modulate the open/closed conformation of RyR1/2 channels measured using [3H]ryanodine binding assays. The affinity constant—KA, for RyR1/2 binding to FKBP12/12.6, was significantly greater for the closed compared with the open conformation. The effect of phosphorylation or K201 was to reduce the KA of the closed conformation by increasing the rate of dissociation kd. K201 reduced [3H]ryanodine binding to RyR1/2 at all free Ca2+ concentrations including PKA phosphorylated preparations.

Conclusion: The results are explained through a model proposing that phosphorylation and K201 acted similarly to change the conformation of RyR1/2 and regulate FKBP12/12.6 binding. K201 stabilized the conformation, whereas phosphorylation facilitated a subsequent molecular event that might increase the rate of an open/closed conformational transition.

KEYWORDS Ryanodine receptor; FKBP12/12.6; Protein kinase A phosphorylation; Arrhythmia (mechanisms); K201


Time for primary review: 29 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.